axieinfinitydao| Kemei Diagnostics (688468.SH): Net profit for the first quarter of 2024 was 38.39 million yuan, a year-on-year increase of 10.21%

On April 30, 2024, Comey diagnosed (688468Axieinfinitydao.sh) release first quarter 2024 results report.

The company realized operating income of 111 million yuan, an increase of 10.36% over the same period last year, and a net profit of 38.39 million yuan, an increase of 10.21% over the same period last year. The net cash flow generated by operating activities was 37.77 million yuan, an increase of 1.07% over the same period last year, and the asset-liability ratio was 23.96%, an increase of 13.71% over the same period last year.

The company's gross profit margin on sales was 77.75%, up 2.13 percentage points from the same period last year, achieving basic earnings per share of 0.10 yuan, an increase of 11.11% over the same period last year, and the rate of return on diluted net assets was 2.78%, up 0.31 percentage points over the same period last year.

The company's inventory turnover rate was 0.22 times, up 0.01 times from the same period last year, and the total asset turnover rate was 0.06 times, down 0.00 times from the same period last year.

The sales cost is about 19.43 million yuan, the management cost is about 11.8 million yuan, and the financial cost is about-1.67 million yuan.

The number of shareholders of the company is 9044, and the number of shares held by the top 10 shareholders is 251 million shares, accounting for 62.62% of the total share capital. The top ten shareholders are Yingweili Enterprise Management Partnership (limited partnership) in Ningbo Free Trade Zone, Shanghai Peixi Investment Management Partnership (Limited Partnership), China Jin Kangrui Phase I (Ningbo) Equity Investment Fund Partnership (limited partnership), Ningbo Free Trade Zone Kobo Enterprise Management Partnership (limited partnership), Hengqin Junlian Zhikang Investment Company (limited partnership), Jiaxing Shenmao No.3 Equity Investment Partnership (Limited Partnership), Dunxin Co., Ltd., Hangzhou Chuangqian Investment Partnership (Limited Partnership), HJ CAPITAL 2 LIMITED, Huahao Investment Management Partnership in Ningbo Meishan Free Trade Port area (Limited Partnership) The shareholding ratios are 26.93%, 6.41%, 5.66%, 4.49%, 4.14%, 3.57%, 3.23%, 2.83%, 2.81% and 2.55%, respectively.

The company's total R & D expenditure is 20.1 million yuan, and R & D expenses account for 18.04% of business income, up 1.11% from the same period last year.

(article sourceAxieinfinitydao: interface news)

Tags:

Prev: megawaysonlineslots| Nanxin Technology traded 629,100 shares at a discount in bulk transactions
Next: baccaratslot88| Industrial Bank Credit Card Center fined 400,000 yuan for lax management of outsourcing collection agencies